| scholarly article | Q13442814 |
| P50 | author | Christopher G. Dowson | Q44019906 |
| P2093 | author name string | E Grace Smith | |
| David Honeybourne | |||
| Joanna L Whitehouse | |||
| David J Waine | |||
| P2860 | cites work | The estimation of the bactericidal power of the blood | Q24651983 |
| The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-gamma-mediated macrophage killing | Q34469399 | ||
| High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. | Q34508854 | ||
| Efficacy and potential for resistance selection of antipseudomonal treatments in a mouse model of lung infection by hypermutable Pseudomonas aeruginosa | Q34509793 | ||
| Hypermutation and the preexistence of antibiotic-resistant Pseudomonas aeruginosa mutants: implications for susceptibility testing and treatment of chronic infections | Q37598703 | ||
| Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function | Q39504806 | ||
| Hypochlorite scavenging by Pseudomonas aeruginosa alginate | Q40163775 | ||
| Detection and susceptibility testing of hypermutable Pseudomonas aeruginosa strains with the Etest and disk diffusion | Q40968218 | ||
| Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation | Q41825397 | ||
| Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections | Q41974061 | ||
| BSAC standardized disc susceptibility testing method (version 5). | Q45086261 | ||
| Alginate lyase enhances antibiotic killing of mucoid Pseudomonas aeruginosa in biofilms | Q46977483 | ||
| Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. | Q47855663 | ||
| Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbation of cystic fibrosis and its impact on the validity of antimicrobial susceptibility testing. | Q53857649 | ||
| Role of mutator alleles in adaptive evolution. | Q54564129 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Pseudomonas aeruginosa | Q31856 |
| phenotype | Q104053 | ||
| P304 | page(s) | 3491-3493 | |
| P577 | publication date | 2008-08-06 | |
| P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
| P1476 | title | Association between hypermutator phenotype, clinical variables, mucoid phenotype, and antimicrobial resistance in Pseudomonas aeruginosa | |
| P478 | volume | 46 |
| Q36409837 | A Low-Molecular-Weight Alginate Oligosaccharide Disrupts Pseudomonal Microcolony Formation and Enhances Antibiotic Effectiveness. |
| Q52685491 | Antibiotic selection in the treatment of acute invasive infections by Pseudomonas aeruginosa: Guidelines by the Spanish Society of Chemotherapy. |
| Q37794342 | Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance |
| Q34491552 | Clinical significance of microbial infection and adaptation in cystic fibrosis |
| Q35350270 | Coexistence and within-host evolution of diversified lineages of hypermutable Pseudomonas aeruginosa in long-term cystic fibrosis infections. |
| Q39097378 | Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis |
| Q38635530 | Current and future therapies for Pseudomonas aeruginosa infection in patients with cystic fibrosis. |
| Q90136995 | Differences in mutational processes and intra-tumour heterogeneity between organs: The local selective filter hypothesis |
| Q99565857 | Distribution of pathogenic bacteria in lower respiratory tract infection in lung cancer patients after chemotherapy and analysis of integron resistance genes in respiratory tract isolates of uninfected patients |
| Q41833848 | Effect of ciprofloxacin concentration on the frequency and nature of resistant mutants selected from Pseudomonas aeruginosa mutS and mutT hypermutators |
| Q28359832 | Evolutionary diversification of Pseudomonas aeruginosa in an artificial sputum model |
| Q38417030 | Evolutionary insight from whole-genome sequencing of Pseudomonas aeruginosa from cystic fibrosis patients |
| Q41366386 | Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation |
| Q28536866 | Genome analysis of a transmissible lineage of pseudomonas aeruginosa reveals pathoadaptive mutations and distinct evolutionary paths of hypermutators |
| Q39656697 | Genotypic and phenotypic variation in Pseudomonas aeruginosa reveals signatures of secondary infection and mutator activity in certain cystic fibrosis patients with chronic lung infections |
| Q36667671 | Hypermutable Pseudomonas aeruginosa in Cystic fibrosis patients from two Brazilian cities. |
| Q89766030 | Hypermutator Pseudomonas aeruginosa exploits multiple genetic pathways to develop multidrug resistance during long-term infections in the airways of cystic fibrosis patients |
| Q58164270 | Meropenem Combined with Ciprofloxacin Combats Hypermutable Pseudomonas aeruginosa from Respiratory Infections of Cystic Fibrosis Patients |
| Q57169588 | Meropenem combined with ciprofloxacin combats hypermutable from respiratory infections of cystic fibrosis patients |
| Q34117477 | Mucoidy, quorum sensing, mismatch repair and antibiotic resistance in Pseudomonas aeruginosa from cystic fibrosis chronic airways infections |
| Q50044377 | Optimization of a meropenem plus tobramycin combination dosage regimen against hypermutable and non-hypermutable Pseudomonas aeruginosa via mechanism-based modeling and the hollow-fiber infection model. |
| Q37274632 | Pharmacodynamics of levofloxacin in a murine pneumonia model of Pseudomonas aeruginosa infection: determination of epithelial lining fluid targets |
| Q35084559 | Pseudomonas aeruginosa: resistance to the max |
| Q38358624 | Small colony variants of Pseudomonas aeruginosa in chronic bacterial infection of the lung in cystic fibrosis |
| Q91623019 | The Essential Role of Hypermutation in Rapid Adaptation to Antibiotic Stress |
| Q33856134 | The complex interplay of iron, biofilm formation, and mucoidy affecting antimicrobial resistance of Pseudomonas aeruginosa |
| Q54652456 | The evolution of bacterial mutation rates under simultaneous selection by interspecific and social parasitism. |
| Q47775468 | Using experimental evolution to identify druggable targets that could inhibit the evolution of antimicrobial resistance |
| Q35813781 | Within-host microevolution of Pseudomonas aeruginosa in Italian cystic fibrosis patients |
Search more.